These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9290790)

  • 1. Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.
    Ben-Ari Z; Shmueli D; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 1997 Sep; 29(6):2687-8. PubMed ID: 9290790
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.
    Karasu Z; Ozacar T; Akyildiz M; Demirbas T; Arikan C; Kobat A; Akarca U; Ersoz G; Gunsar F; Batur Y; Kilic M; Tokat Y
    Antivir Ther; 2004 Dec; 9(6):921-7. PubMed ID: 15651751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive lamivudine against reinfection by hepatitis B after liver transplantation].
    Niederau C
    Z Gastroenterol; 1997 May; 35(5):359-61. PubMed ID: 9265396
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.
    Lu AW; Zheng SS; Wu MP; Shen Y; Yang RW
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):357-61. PubMed ID: 18693169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
    Kim KH; Lee KH; Chang HY; Ahn SH; Tong S; Yoon YJ; Seong BL; Kim SI; Han KH
    J Med Virol; 2003 Nov; 71(3):367-75. PubMed ID: 12966541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.
    Bock CT; Tillmann HL; Torresi J; Klempnauer J; Locarnini S; Manns MP; Trautwein C
    Gastroenterology; 2002 Feb; 122(2):264-73. PubMed ID: 11832441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
    Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus subtypes and lamivudine resistance.
    Marzano A; Ciancio A; Salizzoni M; Rizzetto M; Negro F
    Lancet; 2001 Jul; 358(9276):153-4. PubMed ID: 11469245
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver transplantation for hepatitis B virus cirrhosis].
    Sugawara Y; Makuuchi M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():363-6. PubMed ID: 15453347
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
    Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Endo T; Sakai T; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T; Sawada K
    Bone Marrow Transplant; 2001 Feb; 27(4):433-6. PubMed ID: 11313673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Jonas S; Settmacher U; Neuhaus R; Berg T; Neuhaus P
    Z Gastroenterol; 2002 Sep; 40(9):795-9. PubMed ID: 12215948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
    Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
    Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
    Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
    Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
    Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW
    Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine is safe and effective in fulminant hepatitis B.
    Santantonio T; Mazzola M; Pastore G
    J Hepatol; 1999 Mar; 30(3):551. PubMed ID: 10190743
    [No Abstract]   [Full Text] [Related]  

  • 20. Lamivudine treatment for acute hepatitis B virus infection during allogeneic peripheral blood stem cell transplantation.
    Efremov DG; Georgievski B; Cevreska L; Pivkova A; Panovska I
    Bone Marrow Transplant; 2003 Mar; 31(6):515-6. PubMed ID: 12665850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.